Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study

被引:276
|
作者
Khunti, Kamlesh [1 ,2 ]
Davies, Melanie [1 ,2 ]
Majeed, Azeem [3 ]
Thorsted, Brian Larsen [4 ]
Wolden, Michael Lyng [4 ]
Paul, Sanjoy K. [5 ]
机构
[1] Univ Leicester, Leicester Diabet Ctr, Leicester, Leics, England
[2] Univ Leicester, Leicester Clin Trials Unit, Leicester, Leics, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London, England
[4] Novo Nordisk AS, Bagsvaerd, Denmark
[5] QIMR Berghofer Med Res Inst, Clin Trials & Biostat Unit, Brisbane, Qld, Australia
关键词
GLYCEMIC CONTROL; GLUCOSE CONTROL; COMPLICATIONS; VETERANS; EVENTS;
D O I
10.2337/dc14-0920
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVEHypoglycemia has been associated with an increased risk of cardiovascular (CV) events and all-cause mortality. This study assessed whether, in a nationally representative population, there is an association between hypoglycemia, the risk of CV events, and all-cause mortality among insulin-treated people with type 1 diabetes or type 2 diabetes.RESEARCH DESIGN AND METHODSThis retrospective cohort study used data from the Clinical Practice Research Datalink database and included all insulin-treated patients (30 years of age) with a diagnosis of diabetes.RESULTSIn patients who experienced hypoglycemia, hazard ratios (HRs) for CV events in people with type 1 diabetes were 1.51 (95% CI 0.83, 2.75; P = ns) and 1.61 (1.17, 2.22), respectively, for those with and without a history of CV disease (CVD) before the index date. In people with type 2 diabetes, the HRs for patients with and without a history of CVD were 1.60 (1.21, 2.12) and 1.49 (1.23, 1.82), respectively. For all-cause mortality, HRs in people with type 1 diabetes were 1.98 (1.25, 3.17), and 2.03 (1.66, 2.47), respectively, for those with and without a history of CVD. Among people with type 2 diabetes, HRs were 1.74 (1.39, 2.18) and 2.48 (2.21, 2.79), respectively, for those with and without a history of CVD. The median time (interquartile range) from first hypoglycemia event to first CV event was 1.5 years (0.5, 3.5 years) and 1.5 years (0.5, 3.0 years), respectively, for people with type 1 and type 2 diabetes.CONCLUSIONSHypoglycemia is associated with an increased risk of CV events and all-cause mortality in insulin-treated patients with diabetes. The relationship between hypoglycemia and CV outcomes and mortality exists over a long period.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 50 条
  • [21] Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study
    Yun, Jae-Seung
    Park, Yong-Moon
    Han, Kyungdo
    Cha, Seon-Ah
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
  • [22] Variability in hemoglobin A1c predicts all-cause mortality in patients with type 2 diabetes
    Ma, Wen-Ya
    Li, Hung-Yuan
    Pei, Dee
    Hsia, Te-Lin
    Lu, Kuo-Cheng
    Tsai, Li-Yu
    Wei, Jung-Nan
    Su, Ching-Chieh
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2012, 26 (04) : 296 - 300
  • [23] Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
    Zobel, Emilie H.
    von Scholten, Bernt Johan
    Reinhard, Henrik
    Persson, Frederik
    Teerlink, Tom
    Hansen, Tine W.
    Parving, Hans-Henrik
    Jacobsen, Peter K.
    Rossing, Peter
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [24] Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study
    Andersen, Andreas
    Bagger, Jonatan, I
    Sorensen, Samuel K.
    Baldassarre, Maria P. A.
    Pedersen-Bjergaard, Ulrik
    Forman, Julie L.
    Gislason, Gunnar
    Lindhardt, Tommi B.
    Knop, Filip K.
    Vilsboll, Tina
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [25] Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
    Rawshani, Aidin
    Rawshani, Araz
    Franzen, Stefan
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Miftaraj, Mervete
    McGuire, Darren K.
    Sattar, Naveed
    Rosengren, Annika
    Gudbjornsdottir, Soffia
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (15) : 1407 - 1418
  • [26] Changes in Proteinuria on the Risk of All-Cause Mortality in People with Diabetes or Prediabetes: A Prospective Cohort Study
    Sun, Yang
    Wang, Anxin
    Liu, Xiaoxue
    Su, Zhaoping
    Li, Junjuan
    Luo, Yanxia
    Chen, Shuohua
    Wang, Jianli
    Li, Xia
    Zhao, Zhan
    Zhu, Huiping
    Wu, Shouling
    Guo, Xiuhua
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [27] Evaluating the Incidence and Risk Factors Associated With Mild and Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes
    Chantzaras, Athanasios
    Yfantopoulos, John
    VALUE IN HEALTH REGIONAL ISSUES, 2022, 30 : 9 - 17
  • [28] Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes
    Yun, Jae-Seung
    Ko, Seung-Hyun
    Ko, Sun-Hye
    Song, Ki-Ho
    Yoo, Ki-Dong
    Yoon, Kun-Ho
    Park, Yong-Moon
    Ahn, Yu-Bae
    DIABETES & METABOLISM JOURNAL, 2015, 39 (06) : 498 - 506
  • [29] Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study
    He, Qingfang
    Gao, Mingfei
    Zhou, Xiaoyan
    Wang, Lixin
    Fang, Yujia
    Hu, Ruying
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (07) : 939 - 945
  • [30] Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study
    Ong, G.
    Davis, W. A.
    Davis, T. M. E.
    DIABETOLOGIA, 2010, 53 (07) : 1288 - 1294